# Synthetica Pioneering Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/synthetica-pioneering-co

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Latest round: Series A (Jul 30, 2024)
- Investors on record: 4

## About

Founded in 2023, and based in Shenzhen, China, Synthetica Pioneering Co., Ltd. is a company that focuses on the research and development of live bacterial drugs for the treatment of solid tumors. In July 2024, it closed a series A funding led by new investors Boehringer Ingelheim Venture Fund.

Synthetica Pioneering Co., Ltd. is committed to the research and development of live bacterial drugs and anti-tumor live bacterial drugs.

The company generates revenue by developing live bacterial drugs for the treatment of solid tumors.

The funds will be used to accelerate the company's oncolytic bacterial pipelines into clinical trials.

## Funding rounds

- Series A, Jul 30, 2024 — Temasek Holdings, Boehringer Ingelheim Venture, Lenovo Capital and Incubator Group, Fosun Health Capital

## Investors

- Temasek Holdings — Series A
- Boehringer Ingelheim Venture (https://capitalatlas.ai/funds/boehringer-ingelheim-venture) — Series A
- Lenovo Capital and Incubator Group (https://capitalatlas.ai/funds/lenovo-capital-and-incubator-group) — Series A
- Fosun Health Capital (https://capitalatlas.ai/funds/fosun-health-capital) — Series A